Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Tuberculosis | Research article

Adherence to TB treatment remains low during continuation phase among adult patients in Northwest Ethiopia

Authors: Kassahun Dessie Gashu, Kassahun Alemu Gelaye, Binyam Tilahun

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Patients’ failure to adhere to TB treatment was a major challenge that leads to poor treatment outcomes. In Ethiopia, TB treatment success was low as compared with the global threshold. Despite various studies done in TB treatment adherence, little was known specifically in continuation phase where TB treatment is mainly patient-centered. This study aimed to determine adherence to TB treatment and its determinants among adult patients during continuation phase.

Methods

We deployed a facility-based cross-sectional study design supplemented with qualitative data to explore perspectives of focal healthcare providers. The study population was all adult (≥18 years) TB patients enrolled in the continuation phase and focal healthcare workers in TB clinics. The study included 307 TB patients from 22 health facilities and nine TB focal healthcare providers purposively selected as key-informant. A short (11 questions) version Adherence to Refill and Medication Scale (ARMS) was used for measuring adherence. Data was collected using an interviewer-administered questionnaire and in-depth interview for qualitative data. Binary logistic regression was applied to identify factors associated with patient adherence. We followed a thematic analysis for the qualitative data. The audio data was transcribed, coded and categorized into themes using OpenCode software.

Results

Among 307 participants, 64.2% (95% CI (58.6–69.4%) were adherent to TB treatment during continuation phase. A multi-variable analysis shown that secondary education (AOR = 4.138, 95% CI; 1.594–10.74); good provider-patient relationship (AOR = 1.863, 95% CI; 1.014–3.423); good knowledge on TB treatment (AOR = 1.845, 95% CI; 1.012–3.362) and middle family wealth (AOR = 2.646, 95% CI; 1.360–5.148) were significantly associated with adherence to TB treatment. The majority (58%) of patients mentioned forgetfulness, and followed by 17.3% of them traveling away from home without pills as major reasons for non-adherence to TB treatment.

Conclusions

The study indicated that patients’ adherence to TB treatment remains low during continuation phase. The patient’s education level, knowledge, family wealth, and provider-patient relationship were found positively associated with patient adherence. Forgetfulness, traveling away, and feeling sick were major reasons for non-adherence to TB treatment. Interventional studies are needed on those factors to improve patient adherence to TB treatment during continuation phase.
Literature
2.
go back to reference Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999;3(10 Suppl 2):S231–79.PubMed Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999;3(10 Suppl 2):S231–79.PubMed
3.
go back to reference World Health Organization. Stop TB Dept., World Health Organization. Dept. of HIV/AIDS. Interim policy on collaborative TB/HIV activities. Geneva: World Health Organization; 2004. p. 19. World Health Organization. Stop TB Dept., World Health Organization. Dept. of HIV/AIDS. Interim policy on collaborative TB/HIV activities. Geneva: World Health Organization; 2004. p. 19.
8.
go back to reference WHO. Adherence to long-term therapies: evidence for action. 2003. WHO. Adherence to long-term therapies: evidence for action. 2003.
14.
go back to reference Gube AA, Debalkie M, Seid K, et al. Assessment of anti-TB drug nonadherence and associated factors among TB patients attending TB clinics in Arba Minch governmental health institutions, Southern Ethiopia. Tuberc Res Treatment. 2018;2018:3705812. Gube AA, Debalkie M, Seid K, et al. Assessment of anti-TB drug nonadherence and associated factors among TB patients attending TB clinics in Arba Minch governmental health institutions, Southern Ethiopia. Tuberc Res Treatment. 2018;2018:3705812.
16.
go back to reference Zegeye A, Dessie G, Wagnew F, et al. Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis. PloS one. 2019;14(1):e0210422-e.CrossRef Zegeye A, Dessie G, Wagnew F, et al. Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis. PloS one. 2019;14(1):e0210422-e.CrossRef
19.
go back to reference Mekonnen HS, Azagew AW. Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia. BMC Res Notes. 2018;11(1):691.CrossRef Mekonnen HS, Azagew AW. Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia. BMC Res Notes. 2018;11(1):691.CrossRef
21.
go back to reference Tola HH, Tol A, Shojaeizadeh D, Garmaroudi G. Tuberculosis treatment non-adherence and lost to follow up among TB patients with or without HIV in developing countries: a systematic review. Iran J Public Health. 2015;44(1):1–11.PubMedPubMedCentral Tola HH, Tol A, Shojaeizadeh D, Garmaroudi G. Tuberculosis treatment non-adherence and lost to follow up among TB patients with or without HIV in developing countries: a systematic review. Iran J Public Health. 2015;44(1):1–11.PubMedPubMedCentral
22.
go back to reference Martin C, Perfect T, Mantle G. Non-attendance in primary care: the views of patients and practices on its causes, impact and solutions. Fam Pract. 2005;22(2):38–43. Martin C, Perfect T, Mantle G. Non-attendance in primary care: the views of patients and practices on its causes, impact and solutions. Fam Pract. 2005;22(2):38–43.
23.
go back to reference Neal RD, Hussain-Gambles M, Allgar VL, et al. Reasons for and consequences of missed appointments in general practice in the UK: questionnaire survey and prospective review of medical records. BMC Fam Pract. 2005;47:6. https://doi.org/10.1186/1471-2296-6-47. Neal RD, Hussain-Gambles M, Allgar VL, et al. Reasons for and consequences of missed appointments in general practice in the UK: questionnaire survey and prospective review of medical records. BMC Fam Pract. 2005;47:6. https://​doi.​org/​10.​1186/​1471-2296-6-47.
28.
go back to reference Nunnally J, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994. Nunnally J, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994.
30.
go back to reference Tang Y, Zhao M, Wang Y, et al. Non-adherence to anti-tuberculosis treatment among internal migrants with pulmonary tuberculosis in Shenzhen, China: a cross-sectional study. BMC Public Health. 2015;15:474.CrossRef Tang Y, Zhao M, Wang Y, et al. Non-adherence to anti-tuberculosis treatment among internal migrants with pulmonary tuberculosis in Shenzhen, China: a cross-sectional study. BMC Public Health. 2015;15:474.CrossRef
31.
go back to reference Rutstein SO. The DHS wealth index: Approaches for rural and urban areas. Calverton: Macro International; 2008. Rutstein SO. The DHS wealth index: Approaches for rural and urban areas. Calverton: Macro International; 2008.
37.
go back to reference Mishra P, Hansen EH, Sabroe S, et al. Socio-economic status and adherence to tuberculosis treatment: a case-control study in a district of Nepal. Int J Tuberc Lung Dis. 2005;9(10):1134–9.PubMed Mishra P, Hansen EH, Sabroe S, et al. Socio-economic status and adherence to tuberculosis treatment: a case-control study in a district of Nepal. Int J Tuberc Lung Dis. 2005;9(10):1134–9.PubMed
Metadata
Title
Adherence to TB treatment remains low during continuation phase among adult patients in Northwest Ethiopia
Authors
Kassahun Dessie Gashu
Kassahun Alemu Gelaye
Binyam Tilahun
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06428-6

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.